These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27982680)

  • 1. Distinct response of fat and gastrointestinal tissue to glucose in gestational diabetes mellitus and polycystic ovary syndrome.
    Vejrazkova D; Lischkova O; Vankova M; Stanicka S; Vrbikova J; Lukasova P; Vcelak J; Vacinova G; Bendlova B
    Physiol Res; 2017 May; 66(2):283-292. PubMed ID: 27982680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incretin levels in polycystic ovary syndrome.
    Vrbikova J; Hill M; Bendlova B; Grimmichova T; Dvorakova K; Vondra K; Pacini G
    Eur J Endocrinol; 2008 Aug; 159(2):121-7. PubMed ID: 18511472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
    Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
    Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers and insulin sensitivity in women with Polycystic Ovary Syndrome: Characteristics and predictive capacity.
    Cassar S; Teede HJ; Harrison CL; Joham AE; Moran LJ; Stepto NK
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):50-8. PubMed ID: 25262763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus.
    Cypryk K; Vilsbøll T; Nadel I; Smyczyńska J; Holst JJ; Lewiński A
    Gynecol Endocrinol; 2007 Jan; 23(1):58-62. PubMed ID: 17484514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
    Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.
    Lewandowski KC; Szosland K; O'Callaghan C; Tan BK; Randeva HS; Lewinski A
    Mol Genet Metab; 2005 May; 85(1):61-9. PubMed ID: 15862282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic parameters and perinatal outcomes of gestational diabetes mellitus in women with polycystic ovary syndrome.
    Li G; Fan L; Zhang L; Zhang W; Huang X
    J Perinat Med; 2010 Mar; 38(2):141-6. PubMed ID: 20146658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.
    Zwirska-Korczala K; Sodowski K; Konturek SJ; Kuka D; Kukla M; Brzozowski T; Cnota W; Woźniak-Grygiel E; Jaworek J; Bułdak R; Rybus-Kalinowska B; Fryczowski M
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin action in women with polycystic ovary syndrome and its relation to gestational diabetes.
    de Wilde MA; Goverde AJ; Veltman-Verhulst SM; Eijkemans MJ; Franx A; Fauser BC; Koster MP
    Hum Reprod; 2015 Jun; 30(6):1447-53. PubMed ID: 25840428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy complications and glucose intolerance in women with polycystic ovary syndrome.
    Sawada M; Masuyama H; Hayata K; Kamada Y; Nakamura K; Hiramatsu Y
    Endocr J; 2015; 62(11):1017-23. PubMed ID: 26370557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preserved insulin sensitivity and {beta}-cell activity, but decreased glucose effectiveness in normal-weight women with the polycystic ovary syndrome.
    Gennarelli G; Rovei V; Novi RF; Holte J; Bongioanni F; Revelli A; Pacini G; Cavallo-Perin P; Massobrio M
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3381-6. PubMed ID: 15755857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of polycystic ovaries in women with a history of gestational diabetes.
    Kousta E; Cela E; Lawrence N; Penny A; Millauer B; White D; Wilson H; Robinson S; Johnston D; McCarthy M; Franks S
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):501-7. PubMed ID: 11012576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history.
    Wang D; Zhu W; Li J; An C; Wang Z
    PLoS One; 2013; 8(11):e81190. PubMed ID: 24260557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating adipokines and mRNA expression in adipose tissue and the placenta in women with gestational diabetes mellitus.
    Tsiotra PC; Halvatsiotis P; Patsouras K; Maratou E; Salamalekis G; Raptis SA; Dimitriadis G; Boutati E
    Peptides; 2018 Mar; 101():157-166. PubMed ID: 29337272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
    Barber TM; Casanueva FF; Karpe F; Lage M; Franks S; McCarthy MI; Wass JA
    Eur J Endocrinol; 2008 Apr; 158(4):511-6. PubMed ID: 18362298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of visfatin in the pathogenesis of gestational diabetes mellitus and its relationship with insulin resistance].
    Huo Y; Liu S; Feng J; Li H; Fan Y; Jin Y; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):584-7. PubMed ID: 25354858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes.
    Koivunen RM; Juutinen J; Vauhkonen I; Morin-Papunen LC; Ruokonen A; Tapanainen JS
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2591-9. PubMed ID: 11397859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and follow-up of type 2 diabetes in women with PCOS: a role for OGTT?
    Andersen M; Glintborg D
    Eur J Endocrinol; 2018 Sep; 179(3):D1-D14. PubMed ID: 29921567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.